This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by David R Soto Pantoja
Introduction
David R Soto Pantoja is an innovative inventor based in the United States. He has made significant contributions to the field of cancer treatment through his research and inventions. His work focuses on methods to modulate the effects of chemotherapeutic agents, particularly in reducing their cytotoxicity to non-cancer cells.
Latest Patents
David R Soto Pantoja has disclosed a patent titled "Methods For Modulating Chemotherapeutic Cytotoxicity." This patent outlines methods for reducing the cytotoxicity of chemotherapeutic agents to non-cancer cells by administering an effective amount of an agent that inhibits CD47 signaling alongside the chemotherapeutic agent. The disclosed methods aim to reduce cardiotoxicity associated with these treatments. Additionally, the patent describes methods to increase the cytotoxicity of chemotherapeutic agents in cancer cells by using the same approach.
Career Highlights
Throughout his career, David R Soto Pantoja has focused on advancing cancer treatment methodologies. His innovative approaches have the potential to improve patient outcomes by minimizing the harmful side effects of chemotherapy. His research emphasizes the importance of targeted therapies in oncology.
Collaborations
David R Soto Pantoja has collaborated with David D Roberts, contributing to the development of his innovative methods. Their partnership has been instrumental in advancing the research and application of these techniques in clinical settings.
Conclusion
David R Soto Pantoja is a notable inventor whose work in modulating chemotherapeutic cytotoxicity represents a significant advancement in cancer treatment. His innovative methods have the potential to enhance the efficacy of chemotherapy while reducing its adverse effects.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile